Department of Radiology

Publications

2023

Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. Cancers (Basel). 2023;15(6).

Dev H, Zhu C, Sharbatdaran A, Raza SI, Wang SJ, Romano DJ, et al. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease. J Magn Reson Imaging. 2023;58(4):1153-1160.

Holste G, Jiang Z, Jaiswal A, Hanna M, Minkowitz S, Legasto AC, et al. How Does Pruning Impact Long-Tailed Multi-label Medical Image Classifiers? Med Image Comput Comput Assist Interv. 2023;14224:663-673.

Calvo-Barreiro L, Zhang L, Abdel-Rahman SA, Naik SP, Gabr M. Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells. Int J Mol Sci. 2023;24(2).

Mosconi L, Jett S, Nerattini M, Andy C, Yepez CB, Zarate C, et al. In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology. Res Sq. 2023.

Ozsahin I, Onakpojeruo EP, Uzun B, Ozsahin DU, Butler TA. A Multi-Criteria Decision Aid Tool for Radiopharmaceutical Selection in Tau PET Imaging. Pharmaceutics. 2023;15(4).

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023;50(9):2830-2845.

Carnevale JA, Pandey A, Ramirez-Loera C, Goldberg JL, Bander ED, Henderson F, et al. Endonasal, supraorbital, and transorbital approaches: minimal access endoscope-assisted surgical approaches for meningiomas in the anterior and middle cranial fossae. J Neurosurg. 2023:1-9.

Solomon E. A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive Chemoradiation.. 2023.

Ahad A, Saeed HK, Del Solar V, López-Hernández JE, Michel A, Mathew J, et al. Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. ACS Pharmacol Transl Sci. 2023;6(12):1972-1986.